Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

Differentiated thyroid cancers (DTC) are commonly and successfully treated with total thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only treated with surgery but only intrathyroidal tumors are cured. The worst prognosis is for anaplastic (ATC) and poorly diffe...

Full description

Bibliographic Details
Main Authors: Loredana Lorusso, Virginia Cappagli, Laura Valerio, Carlotta Giani, David Viola, Luciana Puleo, Carla Gambale, Elisa Minaldi, Maria Cristina Campopiano, Antonio Matrone, Valeria Bottici, Laura Agate, Eleonora Molinaro, Rossella Elisei
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
differentiated thyroid cancer
medullary thyroid cancer
targeted therapy
tyrosine kinase inhibitors
sorafenib
lenvatinib
Online Access:https://www.mdpi.com/1422-0067/22/6/3117

Similar Items

Similar Items